The Europe Vascular Patches Market should witness market growth of 6.8% CAGR during the forecast period (2022-2028).
Grafts can be created from a variety of materials, such as polytetrafluoroethylene and Dacron (textile polyester synthetic graft) (PTFE, non-textile synthetic graft). In this treatment, a synthetic graft consisting of pericardium from cows is used. In the form of pericardial patches, the tube grafts have broader uses in open abdominal aortic aneurysm repair procedures.
A big bovine pericardial patch is tailored to the necessary size for aortic reconstruction in order to prepare the pericardial tube graft. The production of pericardial tube grafts using the bovine pericardial patch, which is important for vascular reconstruction in contaminated areas for transplant recipients, is the factor that leads to segment growth.
In general, Central and Eastern Europe have higher death rates from stroke and ischemic heart disease (IHD) than Northern, Southern, and Western Europe. Most European nations, particularly Central and Eastern European nations that experienced significant increases until the dawn of the twenty-first century, are now experiencing declines in CVD mortality.
The Germany market dominated the Europe Vascular Patches Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $37, 258.8 Thousands by 2028. The UK market is anticipated to grow at a CAGR of 6% during (2022-2028). Additionally, The France market would exhibit a CAGR of 7.6% during (2022-2028).
Based on Material, the market is segmented into Biologic and Synthetic. Based on End-user, the market is segmented into Hospitals and Ambulatory Surgical Centers. Based on Application, the market is segmented into Carotid Endarterectomy, Open Repair of Abdominal Aortic Aneurysm, Vascular Bypass Surgery, Congenital Heart Disease and Others. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Edwards Lifesciences Corporation, Baxter International, Inc., Lemaitre Vascular, Inc., Becton, Dickinson and Company, Terumo Corporation, Aziyo Biologics, Inc., Getinge AB, B. Braun Melsungen AG, Artivion, Inc. (CryoLife, Inc.), and W. L. Gore & Associates, Inc.
Grafts can be created from a variety of materials, such as polytetrafluoroethylene and Dacron (textile polyester synthetic graft) (PTFE, non-textile synthetic graft). In this treatment, a synthetic graft consisting of pericardium from cows is used. In the form of pericardial patches, the tube grafts have broader uses in open abdominal aortic aneurysm repair procedures.
A big bovine pericardial patch is tailored to the necessary size for aortic reconstruction in order to prepare the pericardial tube graft. The production of pericardial tube grafts using the bovine pericardial patch, which is important for vascular reconstruction in contaminated areas for transplant recipients, is the factor that leads to segment growth.
In general, Central and Eastern Europe have higher death rates from stroke and ischemic heart disease (IHD) than Northern, Southern, and Western Europe. Most European nations, particularly Central and Eastern European nations that experienced significant increases until the dawn of the twenty-first century, are now experiencing declines in CVD mortality.
The Germany market dominated the Europe Vascular Patches Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $37, 258.8 Thousands by 2028. The UK market is anticipated to grow at a CAGR of 6% during (2022-2028). Additionally, The France market would exhibit a CAGR of 7.6% during (2022-2028).
Based on Material, the market is segmented into Biologic and Synthetic. Based on End-user, the market is segmented into Hospitals and Ambulatory Surgical Centers. Based on Application, the market is segmented into Carotid Endarterectomy, Open Repair of Abdominal Aortic Aneurysm, Vascular Bypass Surgery, Congenital Heart Disease and Others. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Edwards Lifesciences Corporation, Baxter International, Inc., Lemaitre Vascular, Inc., Becton, Dickinson and Company, Terumo Corporation, Aziyo Biologics, Inc., Getinge AB, B. Braun Melsungen AG, Artivion, Inc. (CryoLife, Inc.), and W. L. Gore & Associates, Inc.
Scope of the Study
By Material
- Biologic
- Synthetic
By End-user
- Hospitals
- Ambulatory Surgical Centers
By Application
- Carotid Endarterectomy
- Open Repair of Abdominal Aortic Aneurysm
- Vascular Bypass Surgery
- Congenital Heart Disease
- Others
By Country
- Germany
- UK
- France
- Russia
- Spain
- Italy
- Rest of Europe
Key Market Players
List of Companies Profiled in the Report:
- Edwards Lifesciences Corporation
- Baxter International, Inc.
- Lemaitre Vascular, Inc.
- Becton, Dickinson and Company
- Terumo Corporation
- Aziyo Biologics, Inc.
- Getinge AB
- B.Braun Melsungen AG
- Artivion, Inc. (CryoLife, Inc.)
- W.L. Gore & Associates, Inc.
Unique Offerings
- Exhaustive coverage
- The highest number of Market tables and figures
- Subscription-based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free
Table of Contents
Chapter 1. Market Scope & Methodology1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Europe Vascular Patches Market, by Material
1.4.2 Europe Vascular Patches Market, by End User
1.4.3 Europe Vascular Patches Market, by Application
1.4.4 Europe Vascular Patches Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition & Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Strategies Deployed in Vascular Patches Market
Chapter 4. Europe Vascular Patches Market by Material
4.1 Europe Biologic Market by Country
4.2 Europe Synthetic Market by Country
Chapter 5. Europe Vascular Patches Market by End User
5.1 Europe Hospitals Market by Country
5.2 Europe Ambulatory Surgical Centers Market by Country
Chapter 6. Europe Vascular Patches Market by Application
6.1 Europe Carotid Endarterectomy Market by Country
6.2 Europe Open Repair of Abdominal Aortic Aneurysm Market by Country
6.3 Europe Vascular Bypass Surgery Market by Country
6.4 Europe Congenital Heart Disease Market by Country
6.5 Europe Others Market by Country
Chapter 7. Europe Vascular Patches Market by Country
7.1 Germany Vascular Patches Market
7.1.1 Germany Vascular Patches Market by Material
7.1.2 Germany Vascular Patches Market by End User
7.1.3 Germany Vascular Patches Market by Application
7.2 UK Vascular Patches Market
7.2.1 UK Vascular Patches Market by Material
7.2.2 UK Vascular Patches Market by End User
7.2.3 UK Vascular Patches Market by Application
7.3 France Vascular Patches Market
7.3.1 France Vascular Patches Market by Material
7.3.2 France Vascular Patches Market by End User
7.3.3 France Vascular Patches Market by Application
7.4 Russia Vascular Patches Market
7.4.1 Russia Vascular Patches Market by Material
7.4.2 Russia Vascular Patches Market by End User
7.4.3 Russia Vascular Patches Market by Application
7.5 Spain Vascular Patches Market
7.5.1 Spain Vascular Patches Market by Material
7.5.2 Spain Vascular Patches Market by End User
7.5.3 Spain Vascular Patches Market by Application
7.6 Italy Vascular Patches Market
7.6.1 Italy Vascular Patches Market by Material
7.6.2 Italy Vascular Patches Market by End User
7.6.3 Italy Vascular Patches Market by Application
7.7 Rest of Europe Vascular Patches Market
7.7.1 Rest of Europe Vascular Patches Market by Material
7.7.2 Rest of Europe Vascular Patches Market by End User
7.7.3 Rest of Europe Vascular Patches Market by Application
Chapter 8. Company Profiles
8.1 Edwards Lifesciences Corporation
8.1.1 Company Overview
8.1.2 Financial Analysis
8.1.3 Regional Analysis
8.1.4 Research & Development Expenses
8.1.5 Recent strategies and developments:
8.1.5.1 Product Launches and Product Expansions:
8.1.5.2 Acquisition and Mergers:
8.2 Baxter International, Inc.
8.2.1 Company Overview
8.2.2 Financial Analysis
8.2.3 Regional Analysis
8.2.4 Research & Development Expense
8.2.5 Recent strategies and developments:
8.2.5.1 Acquisition and Mergers:
8.3 Lemaitre Vascular, Inc.
8.3.1 Company Overview
8.3.2 Financial Analysis
8.3.3 Regional Analysis
8.3.4 Research & Development Expenses
8.3.5 Recent strategies and developments:
8.3.5.1 Acquisition and Mergers:
8.4 Becton, Dickinson and Company
8.4.1 Company Overview
8.4.2 Financial Analysis
8.4.3 Segmental and Regional Analysis
8.4.4 Research & Development Expense
8.4.5 Recent strategies and developments:
8.4.5.1 Acquisition and Mergers:
8.5 Terumo Corporation
8.5.1 Company Overview
8.5.2 Financial Analysis
8.5.3 Segmental and Regional Analysis
8.5.4 Regional Analysis
8.5.5 Recent strategies and developments:
8.5.5.1 Product Launches and Product Expansions:
8.6 Aziyo Biologics, Inc.
8.6.1 Company Overview
8.6.2 Financial Analysis
8.6.3 Research & Development Expenses
8.7 Getinge AB
8.7.1 Company Overview
8.7.2 Financial Analysis
8.7.3 Segmental and Regional Analysis
8.7.4 Research & Development Expense
8.8 B. Braun Melsungen AG
8.8.1 Company Overview
8.8.2 Financial Analysis
8.8.3 Segmental and Regional Analysis
8.8.4 Research & Development Expenses
8.9 Artivion, Inc. (CryoLife, Inc.)
8.9.1 Company Overview
8.9.2 Financial Analysis
8.9.3 Segmental and Regional Analysis
8.9.4 Research & Development Expenses
8.10. W. L. Gore & Associates, Inc.
8.10.1 Company Overview
8.10.2 Recent strategies and developments:
8.10.2.1 Acquisition and Mergers:
Companies Mentioned
- Edwards Lifesciences Corporation
- Baxter International, Inc.
- Lemaitre Vascular, Inc.
- Becton, Dickinson and Company
- Terumo Corporation
- Aziyo Biologics, Inc.
- Getinge AB
- B. Braun Melsungen AG
- Artivion, Inc. (CryoLife, Inc.)
- W. L. Gore & Associates, Inc.
Methodology
LOADING...
